SNDX News and Press, Syndax Pharmaceuticals Inc. From 10/24/25

– First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A translocation – – Second approved indication for Revuforj in less than one year further solidifies Syndax’s leadership in me...

2025-10-15 14:30:32 ET My regular readers know that I am not sanguine on the overall market, which I articulated again on Tuesday . Almost one quarter of my portfolio is in short-term treasuries and cash. The rest of my portfolio is almost entirely in covered call positions arou...

Issued on behalf of GT Biopharma, Inc. VANCOUVER – Baystreet.ca News Commentary – The convergence of advanced diagnostics and targeted therapeutics is reshaping cancer care, as September 2025 marked eight FDA oncology approvals [1] spanning breakthrough...

2025-10-09 17:00:00 ET Listen here or on the go via Apple Podcasts and Spotify How to trade and invest in the biotech space with ROTY Biotech Community 's Jonathan Faison (0:35). Making money in biotech (5:40). Managing sector risk (9:20). Geron - a stock he neve...

2025-09-19 12:53:53 ET Last week, Seeking Alpha posted some takes on potential buyouts in the biotech/biopharma sector. Thursday morning, Roche ( OTCQX:RHHBY ) announced it was acquiring 89bio, Inc ( ETNB ) in a deal that could reach $3.5 billion, which included a large buyo...

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the National Comprehensive Cancer Network ® (NCCN ® ) Clinical Practice Guidelines in Onco...

2025-09-10 18:10:25 ET The last time I spoke about Syndax Pharmaceuticals ( SNDX ), it was with respect to a Seeking Alpha article entitled " Syndax: Fall On NPM1m AML Data Of Revumenib Creates Buy Opportunity ." With respect to this article, I noted that the company had...

2025-09-10 12:12:58 ET More on Syndax Pharmaceuticals Syndax Pharmaceuticals, Inc. (SNDX) Presents At Citi's Biopharma Back To School Conference Transcript Syndax Pharmaceuticals: A Tale Of Two Drug Launches Syndax Pharmaceuticals: The Story Brightens Syndax ...

2025-09-05 08:00:00 ET As the beginning of August was yet another buy-the-dip opportunity, are there any compelling investment ideas out there that may have flown under your radar?... Read the full article on Seeking Alpha For further details see: Rare Stock Picks In...

2025-09-02 19:50:30 ET Syndax Pharmaceuticals, Inc. (SNDX) Citi's Biopharma Back to School Conference September 2, 2025 4:45 PM EDT... Read the full article on Seeking Alpha For further details see: Syndax Pharmaceuticals, Inc. (SNDX) Presents At Citi's Biopharma Back To Sch...